Rezolute RZLT
NASDAQ RZLT
$4.07 +0.05 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Rezolute (RZLT) Capital Leases (2014 - 2015)

Updated

Rezolute (RZLT) reported Capital Leases of $23,127 for fiscal Q4 2015 (quarter ended Jun 30, 2015), down 50.7% from the prior quarter.

Analysis

Rezolute (RZLT) Capital Leases (2014 - 2015) Analysis & Trends

Dating back to fiscal Q1 2015, Rezolute's Capital Leases record includes 4 quarters.

  • Per Business Quant data, the three fiscal quarters before Q4 2015 came in at $46,946 (Q3 2015), $70,677 (Q2 2015) and $101,695 (Q1 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rezolute 388.82 Mn -62.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 23,127.00
Mar 31, 2015 46,946.00
Dec 31, 2014 70,677.00
Sep 30, 2014 101,695.00
API Access

Rezolute Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=RZLT&period=max&api_key=YOUR_API_KEY